First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...

Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a third of all human deaths on the planet. Continuous monitoring of hemodynamics – blood flow ...

The vascular delivery (vascular access) device market in Brazil is growing and was valued at nearly $59 million in 2012. Recent growth over is primarily due to the increasing size and age of the ...

Table I. Relevant U.S. and European standards (click to enlarge). Wireless systems enabled by low-power radio technology are delivering mobility, comfort, and higher levels of patient care. Both ...

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial ...

NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica ...